Singular Genomics Systems Inc (OMIC)
19.35
+0.09
(+0.47%)
USD |
NASDAQ |
Dec 24, 16:00
Singular Genomics Systems Cash from Financing (Quarterly): 0.00 for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Bruker Corp | -2.70M |
| Azenta Inc | -247.55M |
| Harvard Bioscience Inc | 2.104M |
| Bionano Genomics Inc | 6.021M |
| Akoya Biosciences Inc | -0.15M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -19.79M |
| Cash from Investing (Quarterly) | 42.29M |
| Free Cash Flow | -80.86M |
| Free Cash Flow Per Share (Quarterly) | -7.914 |
| Free Cash Flow to Equity (Quarterly) | -18.61M |
| Free Cash Flow Yield | -168.3% |